ALKERMES reported 1.05B in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Amgen AMGN:US $ 19322M 802M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Gilead Sciences GILD:US $ 13705M 1076M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Horizon Pharma HZNP:US $ 3203.09M 255.36M
Intra Cellular Therapies ITCI:US $ 789.21M 59.14M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Marinus Pharmaceuticals MRNS:US $ 101.09M 33.98M
Minerva Neurosciences NERV:US $ 50.04M 5.66M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Otsuka Holdings 4578:JP Y 1152178M 86282M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M